202 related items for PubMed ID: 11588659
1. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
Heering P, Schneider A, Grabensee B, Plum J.
Dtsch Med Wochenschr; 2001 Oct 05; 126(40):1093-8. PubMed ID: 11588659
[Abstract] [Full Text] [Related]
2. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
Ittel TH, Clasen W, Fuhs M, Kindler J, Mihatsch MJ, Sieberth HG.
Clin Nephrol; 1995 Sep 05; 44(3):156-62. PubMed ID: 8556831
[Abstract] [Full Text] [Related]
3. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
Zietse R, Wenting GJ, Kramer P, Schalekamp MA, Weimar W.
Clin Sci (Lond); 1992 Jun 05; 82(6):641-50. PubMed ID: 1320544
[Abstract] [Full Text] [Related]
4. [Indications for cyclosporin in the treatment of idiopathic nephrotic syndrome in adults].
Zietse R, Weimar W.
Ned Tijdschr Geneeskd; 1992 Sep 05; 136(36):1749-53. PubMed ID: 1407123
[No Abstract] [Full Text] [Related]
5. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
Am J Kidney Dis; 2003 Jan 05; 41(1):38-48. PubMed ID: 12500220
[Abstract] [Full Text] [Related]
6. The impact of sex in primary glomerulonephritis.
Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S, Genes, Gender and Glomerulonephritis Group.
Nephrol Dial Transplant; 2008 Jul 05; 23(7):2247-53. PubMed ID: 18182409
[Abstract] [Full Text] [Related]
7. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
Clin Nephrol; 1995 Jun 05; 43(6):375-81. PubMed ID: 7554521
[Abstract] [Full Text] [Related]
8. [Advances in the treatment of adult nephrotic syndrome].
Yokoyama H, Asaka M, Yamaya H, Wada T.
Nihon Jinzo Gakkai Shi; 2007 Jun 05; 49(2):108-12. PubMed ID: 17375618
[No Abstract] [Full Text] [Related]
9. Contrasting response to cyclosporin in refractory nephrotic syndrome.
Zietse R, Wenting GJ, Kramer P, Mulder P, Schalekamp MA, Weimar W.
Clin Nephrol; 1989 Jan 05; 31(1):22-5. PubMed ID: 2914407
[Abstract] [Full Text] [Related]
10. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
Am J Nephrol; 2007 Jan 05; 27(3):226-31. PubMed ID: 17389782
[Abstract] [Full Text] [Related]
11. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
Ferrari P, Frey FJ.
Ther Umsch; 1993 Feb 05; 50(2):119-29. PubMed ID: 8456416
[Abstract] [Full Text] [Related]
12. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
Duncan N, Dhaygude A, Owen J, Cairns TD, Griffith M, McLean AG, Palmer A, Taube D.
Nephrol Dial Transplant; 2004 Dec 05; 19(12):3062-7. PubMed ID: 15507477
[Abstract] [Full Text] [Related]
13. Cyclosporin A treatment for idiopathic membranous nephropathy.
Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L.
Chin Med J (Engl); 2001 Dec 05; 114(12):1305-8. PubMed ID: 11793859
[Abstract] [Full Text] [Related]
14. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
Frassinetti Castelo Branco Camurça Fernandes P, Bezerra Da Silva G, De Sousa Barros FA, Costa Oliveira CM, Kubrusly M, Evangelista JB.
J Nephrol; 2005 Dec 05; 18(6):711-20. PubMed ID: 16358229
[Abstract] [Full Text] [Related]
15. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May 05; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
16. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
Nephrol Dial Transplant; 2005 Apr 05; 20(4):735-42. PubMed ID: 15772265
[Abstract] [Full Text] [Related]
17. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov 05; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
18. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM, Catarsi P, Scolari F, Caridi G, Bertelli R, Carrea A, Sanna-Cherchi S, Emma F, Allegri L, Cancarini G, Rizzoni GF, Perfumo F.
Clin Ther; 2004 Sep 05; 26(9):1411-8. PubMed ID: 15531003
[Abstract] [Full Text] [Related]
19. Renal outcome after ciclosporin-induced nephrotoxicity.
Tostivint I, du Montcel ST, Jaudon MC, Mallet A, Le Hoang P, Bodaghi B, Deray G, Bagnis CI.
Nephrol Dial Transplant; 2007 Mar 05; 22(3):880-5. PubMed ID: 17127700
[Abstract] [Full Text] [Related]
20. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
Bomback AS, Canetta PA, Beck LH, Ayalon R, Radhakrishnan J, Appel GB.
Am J Nephrol; 2012 Mar 05; 36(1):58-67. PubMed ID: 22722778
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
